Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2010. Start Trial.
Date Value
October 23, 2026 2.192B
October 22, 2026 2.154B
October 21, 2026 2.314B
October 20, 2026 2.281B
October 19, 2026 1.980B
October 16, 2026 1.877B
October 15, 2026 2.152B
October 14, 2026 2.261B
October 13, 2026 2.368B
October 12, 2026 2.271B
October 09, 2026 2.215B
October 08, 2026 2.136B
October 07, 2026 2.146B
October 06, 2026 2.152B
October 05, 2026 2.211B
October 02, 2026 2.233B
October 01, 2026 2.150B
September 30, 2026 2.348B
September 29, 2026 2.186B
September 28, 2026 2.203B
September 25, 2026 2.207B
September 24, 2026 2.281B
September 23, 2026 2.188B
September 22, 2026 2.289B
September 21, 2026 2.158B
Date Value
September 18, 2026 2.182B
September 17, 2026 2.190B
September 16, 2026 2.217B
September 15, 2026 2.142B
September 14, 2026 2.230B
September 11, 2026 2.193B
September 10, 2026 2.586B
September 09, 2026 2.679B
September 08, 2026 2.681B
September 04, 2026 2.661B
September 03, 2026 2.629B
September 02, 2026 2.721B
September 01, 2026 2.532B
August 31, 2026 2.556B
August 28, 2026 2.530B
August 27, 2026 2.933B
August 26, 2026 2.635B
August 25, 2026 2.707B
August 24, 2026 2.755B
August 21, 2026 2.984B
August 20, 2026 2.568B
August 19, 2026 2.659B
August 18, 2026 2.507B
August 17, 2026 2.487B
August 14, 2026 2.443B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AbbVie, Inc. 569.05B
ImmunityBio, Inc. 9.529B
TG Therapeutics, Inc. 8.494B
Capricor Therapeutics, Inc. 197.70M
Relay Therapeutics, Inc. 3.093B

Enterprise Value Related Metrics